IRVINE, Calif. (AP) _ OncoCyte Corp. (OCX) on Monday reported a loss of $3.9 million in its first quarter.
The Irvine, California-based company said it had a loss of 5 cents per share. Losses, adjusted for non-recurring costs, were 4 cents per share.
The cancer diagnostic test developer posted revenue of $1.1 million in the period.
In the final minutes of trading on Monday, the company's shares hit $4.05. A year ago, they were trading at $2.88.
The Associated Press